+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07655583

A Pilot Study Evaluating Omission of Post-Operative Brain Radiation After Resection of Melanoma or NSCLC Brain Metastases with CNS-Active Systemic Therapy

Led by M.D. Anderson Cancer Center · Updated on 2026-09-15

20

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the risk of cancer recurrence in the area where a brain tumor was removed in patients with melanoma or non-small cell lung cancer NSCLC brain metastases. This study focuses on patients who receive highly active systemic therapies that affect the central nervous system CNS without the usual follow-up radiation to the surgical site. The goal is to understand if omitting postoperative radiation is safe and effective in preventing tumor return. Participants will start CNS-active systemic therapy recommended by their oncologist within five weeks after brain tumor surgery. The systemic therapies include dual-agent immune checkpoint inhibitors for melanoma and targeted drugs like osimertinib or brigatinib for specific genetic types of NSCLC. No radiation therapy to the surgical site will be given after surgery. During the first two years, participants will have study visits every 12 weeks and undergo neurocognitive function assessments at specific time points. After two years, their medical records will be reviewed periodically unless they withdraw from the study. Throughout the study, participants will be closely monitored for safety and side effects, with an average follow-up of about one year. Researchers will track the occurrence of surgical bed recurrence and adverse events related to the systemic therapy. The study may last up to four years from enrollment, with ongoing health status reviews beyond two years. Participants will undergo regular brain imaging and cognitive testing to assess treatment impact and brain health during the study.

CONDITIONS

Brief Title

OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy

Research Team

T

Thomas H Beckham, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here